Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-07-29
2008-07-29
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07405199
ABSTRACT:
This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
REFERENCES:
patent: 5693791 (1997-12-01), Truett et al.
patent: 6392012 (2002-05-01), Judice et al.
patent: 6437119 (2002-08-01), Truett et al.
patent: 6635618 (2003-10-01), Leadbetter et al.
patent: 6974797 (2005-12-01), Fatheree et al.
patent: 7067481 (2006-06-01), Fatheree et al.
patent: 7067482 (2006-06-01), Fatheree et al.
patent: 7127856 (2006-10-01), Hagen et al.
patent: 7279458 (2007-10-01), Fatheree et al.
patent: 2003/0008812 (2003-01-01), Christensen et al.
patent: 2005/0049193 (2005-03-01), Grasso et al.
patent: WO 99/42476 (1999-08-01), None
patent: WO 99/64049 (1999-12-01), None
patent: WO 00/39156 (2000-07-01), None
patent: WO 01057071 (2001-08-01), None
patent: WO 03/031449 (2003-04-01), None
Pavlov, et al., A New Type of Chemical Modification of Glycopeptides Antibiotics: Aminomethylated Derivatives of Eremomycin and Their Antibacterial Activity, The Journal of Antibiotics, 1997, vol. 50, No. 6, pp. 509-513.
U.S. Appl. No. 09/457,926, filed Dec. 8, 1999, Christensen et al.
Fatheree Paul
Leadbetter Michael R.
Linsell Martin S.
Marquess Daniel
Hagenah Jeffrey A.
Harle Jennifer I.
Tate Christopher R.
Theravance Inc.
LandOfFree
Cross-linked glycopeptide-cephalosporin antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cross-linked glycopeptide-cephalosporin antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cross-linked glycopeptide-cephalosporin antibiotics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2815855